Compound Detail
CHEMBL4533346
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL4533346 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | FAGLLDNUXYLWHY-UHFFFAOYSA-N |
4
Targets
4
Activities
1
Assay Types
0
PK Parameters
6
Publications
0
Known Names
Molecular Properties
413.5
MW (Da)
2.11
ALogP
8
HBA
3
HBD
121.2
PSA (Ų)
0.28
QED
0
Ro5 Violations
9
Rot. Bonds
Drug Information
| Molecule Type | Unknown |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 4 meas. best 7.82
Target Activity Profile
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Raji | IC50 | = | 15.3 | nM | 7.82 | Antiproliferative activity against human Raji cells after 72 hrs by MTT assay | 30629434 |
| MM1.S | IC50 | = | 52.3 | nM | 7.28 | Antiproliferative activity against human MM1S cells after 72 hrs by MTT assay | 30629434 |
| HCT-116 | IC50 | = | 106.9 | nM | 6.97 | Antiproliferative activity against human HCT116 cells after 72 hrs by MTT assay | 30629434 |
| MCF7 | IC50 | = | 180.4 | nM | 6.74 | Antiproliferative activity against human MCF7 cells after 72 hrs by MTT assay | 30629434 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 30629434 | 10.1021/acs.jmedchem.8b01825 | MCF7 | 1 |
| 30629434 | 10.1021/acs.jmedchem.8b01825 | MM1.S | 1 |
| 30629434 | 10.1021/acs.jmedchem.8b01825 | HCT-116 | 1 |
| 30629434 | 10.1021/acs.jmedchem.8b01825 | Raji | 1 |
| 30629434 | 10.1021/acs.jmedchem.8b01825 | PI3-kinase p110-alpha/p85-alpha | 1 |
| 30629434 | 10.1021/acs.jmedchem.8b01825 | Serine/threonine-protein kinase mTOR | 1 |
Data from ChEMBL 36 via Core Engine